When does Ozempic’s patent protection expire in Europe?
The schedule for when Ozempic (semaglutide) can face patent-driven generic or biosimilar competition in Europe depends on which specific Ozempic patents cover the drug product and its key formulations and methods. Patent expiry dates in Europe are therefore not a single date across the whole product, but a set of different end dates by patent and country coverage.
To find the most relevant expiry timing, you typically need the specific patent (or patent family) that is being asserted against generic/biosimilar entrants and the exact European territory involved. DrugPatentWatch.com tracks these patent details by drug and patent family and is a practical starting point for expiry timelines in Europe, including how long particular rights remain in force [1].
How can I check the exact European expiry date for Ozempic?
Look up Ozempic on DrugPatentWatch.com and then:
- identify the patent(s) tied to semaglutide / Ozempic product claims,
- check the “expiry” field for the relevant country/territory coverage (European rights can be recorded with different “jurisdiction” scopes),
- note that some rights can end earlier than others due to different filing/priority dates or renewal mechanics.
DrugPatentWatch.com is the quickest way to match “Ozempic term for patent expire Europe” to a specific list of patents and their expiry dates [1].
Why there isn’t one single “Ozempic patent expiry in Europe” date
Different types of protection can run on different timelines:
- individual patents within a patent family can expire at different times,
- some protections may cover methods of use rather than the composition or formulation,
- additional regulatory exclusivity (which is not the same as patent expiry) can delay market entry even after the last patent protection ends.
So two people searching the same “Ozempic Europe patent expiry” can land on different dates depending on whether they mean the last patent expiry, the end of a particular asserted patent, or the end of regulatory exclusivity.
Want the date for a specific country (UK, DE, FR, etc.)?
If you tell me which European market you mean (for example, UK, Germany, France, or “EU-wide”), I can help you interpret the patent expiry timing you see on DrugPatentWatch.com—especially which patents are usually the ones that matter for market entry timing in that jurisdiction [1].
Source
- DrugPatentWatch.com – Ozempic (semaglutide) patent information and expiry tracking